Abstract: A high-gain miniaturized antenna element includes a radiation structure and a feed support structure. The radiation structure includes a first radiator and a second radiator. The first radiator is arranged horizontally. The second radiator is formed by bending an outer edge of the first radiator downwardly. The feed support structure includes a plurality of feed support parts arranged vertically. Each feed support part is a downward extension of the first radiator.

Abstract: This application can provide a method and electronic device for separating mixed sound signal. The method includes: obtaining a first hidden variable representing a human voice feature and a second hidden variable representing an accompaniment sound feature by inputting feature data of a mixed sound extracted from a mixed sound signal into a coding model for the mixed sound; obtaining first feature data of a human voice and second feature data of an accompaniment sound by inputting the first hidden variable and the second hidden variable into a first decoding model for the human voice and a second decoding model for the accompaniment sound respectively; and obtaining, based on the first feature data and the second feature data, the human voice and the accompaniment sound.

Abstract: A processor core, a processor, an apparatus, and an instruction processing method are disclosed. The processor core includes: an instruction fetch unit, where the instruction fetch unit includes a speculative execution predictor and the speculative execution predictor compares a program counter of a memory access instruction with a table entry stored in the speculative execution predictor and marks the memory access instruction; a scheduler unit adapted to adjust a send order of marked memory access instructions and send the marked memory access instructions according to the send order; an execution unit adapted to execute the memory access instructions according to the send order. In the instruction fetch unit, a memory access instruction is marked according to a speculative execution prediction result. In the scheduler unit, a send order of memory access instructions is determined according to the marked memory access instruction and the memory access instructions are sent.

Abstract: An LED filament and an LED light bulb applying the same are provided. The LED filament includes a conductive section including a conductor; two or more LED sections connected to each other by the conductive section, and each of the LED sections includes two or more LED chips electrically connected to each other through a wire; two electrodes, electrically connected to the LED section; and a light conversion layer with a top layer and a base layer, covering the LED sections, the conductive section and the two electrodes, and a part of each of the two electrodes is exposed respectively. The LED filament is supplied with electric power no more than 8 W, when the LED filament is lit, at least 4 lm of white light is emitted per millimeter of filament length.

Abstract: A micro-fluxgate sensor has a double-iron core assembly, a self-oscillating module, a current superimposing and amplifying module and a voltage acquisition module. The double-iron core assembly comprises a first iron core and a second iron core. The first iron core is provided with a first winding coil. The second iron core is provided with a second winding coil. The first winding coil and the second winding coil are respectively connected with an input end of the self-oscillating module, and an output end of the self-oscillating module is respectively connected with the current superimposing and amplifying module and the voltage acquisition module. The fluxgate sensor is simple in processing circuit without manual debugging and is easily integrated.

Abstract: An LED lighting device comprise a first portion, wherein a lamp cap is disposed thereof, wherein the lamp cap extends in a first direction; a second portion, wherein a case and a power supply are disposed thereof, wherein the power supply is disposed in the case; a third portion. A heat exchange unit and a light emission unit are disposed thereof, the light emission unit and the heat exchange unit are connected and form a thermal conduction path, the light emission unit and the power supply are electrically connected, When the first direction is parallel to the horizontal plane, the light emitting unit of the LED lighting device provides downward light emission when working. The first portion, the second portion and the third portion are arranged sequentially. The LED lighting device is installed horizontally, wherein after the lamp cap is disposed, the moment is F=d1*g*W1+(d2+d3)*g*W2, wherein the moment satisfies the following formula: 1 NM<d1*g*W1+(d2+d3)*g*W2<2 NM.

Abstract: An oxaazaquinazolin-7(8H)-ketone compound with a selective inhibition effect on KRAS gene mutation and pharmaceutically acceptable salts thereof, stereoisomers, solvent compounds or prodrugs (as shown in formula I or formula II, see the details of the definition to each group in the formulas in the specification), as well as the pharmaceutical composition containing the compound, and the application thereof in preparation of cancer medicine.

Abstract: A 5G antenna unit includes: a feed stalk including two support plates intersected with each other; a radiation structure disposed at a first end of the feed stalk and including a radiation surface away from the first end of the feed stalk; and a feed board disposed at a second end of the feed stalk. One end of each of the two support plates adjacent to the radiation structure partially passes through the radiation surface of the radiation structure to fix and support the radiation structure. Each support plate is provided with at least two feed lines for coupling with the radiation surface. An end surface of the feed board adjacent to the feed board is provided with a feed network including a plurality of feed points. Each feed point is electrically connected to one of the feed lines to form a feeding structure including at least two feed points of the plurality of feed points.

Abstract: Described are a number of aptamers that are specific to bind with peptidoglycan (“PGN”) with specificity over counter-targets lipopolysaccharides (“LPS”) and lipoteichoic acid (“LTA”), and associated methods.

Abstract: Described are a number of aptamers that are specific to bind with lipopolysaccharide (LPS), and associated methods.

Abstract: Described are a number of aptamers that are specific to bind with lipoteichoic acid (LTA), and associated methods.

Abstract: The present invention provides uses of a compound represented by formula A in the preparation of drugs for treating brain glioma and particularly glioblastoma. Particularly provided are uses of the compound represented by formula A in the preparation of drugs for treating expression of specific fusion protein. By means of the technical solution of the present invention, typing of brain glioblastoma can be implemented, a drug administration can be carried out for a specific patient group, and precise treatment can be implemented.

Abstract: An LED lighting device comprise a lamp cap; a case, connected to the lamp cap and having a cavity; a power supply disposed in the cavity of the case; a heat exchange unit comprises a first heat spreader and a second heat spreader, the heat exchange unit has a folded state and an expanded state, and the heat exchange unit can be switched between the folded state and the expanded state, the heat exchange unit has a width dimension A in the folded state and has a width dimension B in the expanded state, the width dimension A of the heat exchange unit in the folded state is less than the width dimension B of the heat exchange unit in the expanded state, and a light emission unit, the light emission unit and the heat exchange unit are connected to form a thermal conduction path, the light emission unit and the power supply are electrically connected.

Abstract: A substituted dihydropyrazole compound as shown in formula I, which compound has a selective inhibitory effect on RIPK1, and a pharmaceutically acceptable salt, a stereoisomer, a solvate or a prodrug thereof, wherein the definition of each group in the formula is detailed in the description. In addition is a pharmaceutical composition containing the compound, and the use thereof in the preparation of a drug for treating RIPK1-related diseases or conditions.

Abstract: A suitcase bottom shell and the suitcase having a bottom case are provided. The suitcase bottom shell includes a shell body; the shell body is provided with universal wheels and further provided with storage grooves; and the universal wheels are stored in the storage grooves. By arranging the storage grooves on the shell body, the universal wheels are stored in the storage grooves when the suitcase needs to be laid aside, and the universal wheels are taken out from the storage grooves when the suitcase needs to be used to achieve a stability as well as convenience and efficiency; by arranging limiting mechanisms, the universal wheels keep unfolded for sliding without being stored by mistake when the suitcase is in normal use, or keep stored without extending and sliding by accident when the suitcase is laid aside.

Abstract: The disclosure provides a catalyst system and a method for ethylene oligomerization using this. The catalyst system contains: ligand a, containing carbene groups of imidazole ring type; transition metal compound b, that is one of IVB˜VIII group metal compounds; activator c, that is a compound containing III A group metals; the ligand a contains at least one group as shown in general formula I: in which, bridging group A contains a main chain including alkyl, alkenyl, aryl groups or the combination of them and the first heteratom; E is a linear or cyclic group containing the second heteroatom; R is a hydrocarbyl group. The catalyst system is especially used for trimerization and tetramerization of ethylene. The catalyst system has high selectivity for 1-hexene and 1-octene, low selectivity for 1-butene and 1-C10+, and the total percent content of C6˜C8 linear ??-olefin in the product is more than 90% by mass.

Abstract: The present invention provides a microcrystalline glass product. The microcrystalline glass product includes the following components in percentage by weight: SiO2: 45-70%; Al2O3: 8-18%; Li2O: 10-25%; ZrO2: 5-15%; P2O5: 2-10%; and Y2O3: greater than 0 but less than or equal to 8%. Through reasonable component design, the microcrystalline glass and the microcrystalline glass product obtained in the present invention have excellent mechanical and optical properties and are suitable for electronic devices or display devices.

Abstract: A polypeptide magnetic nanoparticle, comprising: a specific targeting polypeptide and a magnetic nanoparticle. The amino acid sequence of the specific targeting polypeptide is VRRDAPRFSMQGLDA-X, and the C-terminal X thereof is a sequence of 5 to 20 amino acids. The amino acid in the amino acid sequence of C-terminal X is selected from one or more of: C, G, and N. The polypeptide magnetic nanoparticle can be used for CTC detection and molecular typing of various cancer types, including esophageal cancer, liver cancer, lung cancer, stomach cancer, bladder cancer, skin cancer, melanoma, breast cancer, colorectal cancer, cervical cancer, etc. Biomarkers of CTC molecular typing include PD-L1, HER2, ER, PR, AR, EGFR, VEGFR, CXCR4, etc. The polypeptide magnetic nanoparticle is helpful for CTC detection and the qualitative and semiquantitative analysis of expression levels of biomarkers at CTC level, thereby performing precise therapy such as targeted individualized targeted therapy or immunotherapy on patients.

Abstract: The present invention is directed to compounds according to Formula I as well as to stereoisomer, tautomer or pharmaceutically acceptable salts of such compounds. The invention also is directed to pharmaceutically acceptable compositions containing such compounds and associated methods for preparing and effect dose in treatment as well as the application in preparing medicine for preventing and/or treating cancers. The invention provides the novel derivatives which introduce methylenedioxy in the position of 10,11 and different groups in the position of 7. The derivatives of novel structure, and the raw materials are easily to obtain. In addition, the compounds in this invention have good cytotoxic activity in vitro and anti-tumor activity in vivo. Therefore, this kind of compounds have broad application foreground.